NCT05388461

Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy

Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy for Severe or Treatment Resistant Depression - Predictors of Response, Side Effects, and Relapse

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 600 (estimated)
• Sponsor: Haukeland University Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The overall aim of the current project is to assess the acute and long term outcome of ECT (both patient and clinician rated) in a non-selected patient cohort from ordinary clinical activity, and to seek out factors predicting response and remission, side effects and relapse.

Detailed description

Patients reffered to electroconvulsive ECT are (after written consent) enroled in a research registry. Based on (clinician and patient rated) measures of depressive symptoms and overall cognitive function, the short and long-term (6 months) efficacy of ECT will be described, and factors predicting response and relapse identified. The duration of possible cognitive impairment and factors predicting cognitive outcome will be examined.

Conditions

• Depressive Disorder

Interventions

Type	Name	Description
OTHER	electroconvulsive therapy	electroconvulsive therapy

Timeline

• Start date: 2013-03-13
• Primary completion: 2028-12-01
• Completion: 2028-12-01
• First posted: 2022-05-24
• Last updated: 2023-09-26

Locations

2 sites across 1 country: Norway